Predictive Oncology Inc.
POAI
$0.96
-$0.03-3.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.79M | -9.57M | -10.88M | -10.88M | -11.62M |
| Total Depreciation and Amortization | 903.90K | 890.30K | 834.60K | 834.60K | 850.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 492.40K | 53.40K | 287.00K | 287.00K | 397.20K |
| Change in Net Operating Assets | 274.60K | -156.50K | 37.50K | 37.50K | 297.20K |
| Cash from Operations | -6.12M | -8.78M | -9.72M | -12.82M | -13.18M |
| Capital Expenditure | -6.50K | -9.50K | 6.00K | 6.00K | -242.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 625.00K | 0.00 | -8.20K | -8.20K | -11.90K |
| Cash from Investing | 618.50K | -9.50K | -2.20K | -6.10K | -258.70K |
| Total Debt Issued | 275.10K | 275.10K | 275.10K | 275.10K | 0.00 |
| Total Debt Repaid | -233.80K | -346.20K | -260.20K | -260.20K | -222.20K |
| Issuance of Common Stock | 6.28M | 3.70M | 3.70M | 3.70M | -- |
| Repurchase of Common Stock | -- | -- | -1.50K | -1.50K | -1.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -653.50K | -573.80K | -573.80K | -573.80K | -- |
| Cash from Financing | 5.66M | 3.05M | 3.14M | 3.40M | 36.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 158.50K | -5.74M | -6.58M | -9.43M | -13.40M |